0.511
-0.04 (-7.84%)
| Previous Close | 0.555 |
| Open | 0.520 |
| Volume | 195,007 |
| Avg. Volume (3M) | 585,183 |
| Market Cap | 5,834,943 |
| Price / Sales | 43.47 |
| Price / Book | 3.04 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2025 |
| Diluted EPS (TTM) | -0.800 |
| Total Debt/Equity (MRQ) | 5.05% |
| Current Ratio (MRQ) | 4.86 |
| Operating Cash Flow (TTM) | -5.51 M |
| Levered Free Cash Flow (TTM) | -2.99 M |
| Return on Assets (TTM) | -78.05% |
| Return on Equity (TTM) | -141.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | Bullfrog AI Holdings, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.50 |
|
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| % Held by Insiders | 25.43% |
| % Held by Institutions | 4.51% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rise Advisors, Llc | 30 Sep 2025 | 0 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 04 Feb 2026 | Announcement | BullFrog AI to Unveil New Precision AI Capability |
| 27 Jan 2026 | Announcement | BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences |
| 06 Jan 2026 | Announcement | BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer |
| 30 Dec 2025 | Announcement | BullFrog AI Publishes Annual Letter to Shareholders |
| 28 Nov 2025 | Announcement | BullFrog AI and Myriad Uranium Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |